(Q30433612)

11 November 2017

Safety and pharmacokinetics of repeat-dose micafungin in young infants (English)

1 reference

11 November 2017

1 reference

11

1 reference

11 November 2017

D K Benjamin

1

1 reference

11 November 2017

P B Smith

2

1 reference

11 November 2017

A Arrieta

3

1 reference

11 November 2017

L Castro

4

1 reference

11 November 2017

P J Sánchez

5

1 reference

11 November 2017

D Kaufman

6

1 reference

11 November 2017

L J Arnold

7

1 reference

11 November 2017

L L Kovanda

8

1 reference

11 November 2017

T Sawamoto

9

1 reference

11 November 2017

D N Buell

10

1 reference

11 November 2017

T J Walsh

12

1 reference

11 November 2017

language of work or name

English

0 references

publication date

4 November 2009

1 reference

Clinical Pharmacology & Therapeutics

11 November 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 November 2017

87

1 reference

11 November 2017

1

1 reference

11 November 2017

93-99

1 reference

Pharmacokinetics of an elevated dosage of micafungin in premature neonates

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Micafungin: pharmacology, experimental therapeutics and clinical applications

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Empirical therapy for neonatal candidemia in very low birth weight infants

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Fluconazole prophylaxis against fungal colonization and infection in preterm infants

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques

20 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.200

Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.200

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.200

National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.200

Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.200

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.200

Caspofungin therapy of neonates with invasive candidiasis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2824925

A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19890251

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Linear pharmacokinetics of micafungin and its active metabolites in Japanese pediatric patients with fungal infections

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19890251

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/CLPT.2009.200

1 reference

11 November 2017

1 reference

11 November 2017

PubMed publication ID

19890251

1 reference